Cabergoline and Nausea

This is a study of Nausea among people who take Cabergoline. The study analyzes: the time on Cabergoline when people have Nausea, age of these people, the severity of Nausea, how they recovered, and common conditions and drugs used besides Cabergoline. In total 2,095 Cabergoline users are studied. The study is created by eHealthMe based on reports from FDA and is updated regularly.

Do you have chronic disease and take multiple drugs? eHealthMe can monitor your drugs and notify you when there are serious drug reactions detected. Our original studies have been used on premier medical publications. The monitor will be personalized to your gender and age. Start now

Cabergoline

Cabergoline has active ingredients of cabergoline. It is used in prolactinoma, pituitary tumor, hyperprolactinaemia, pituitary tumour, pituitary tumour benign. Commonly reported side effects of Cabergoline include mitral valve incompetence, pleural effusion, aortic valve incompetence, breathing difficulty, cardiac failure.

Nausea

Nausea has been reported by people with type 2 diabetes, quit smoking, high blood pressure, depression, pain.

On May, 23, 2013: 2,095 people reported to have side effects when taking Cabergoline. Among them, 59 people (2.82%) have Nausea.

Time on Cabergoline when people have Nausea * :

Age of people who have Nausea when taking Cabergoline * :

Severity of Nausea when taking Cabergoline ** :

How people recovered from Nausea ** :

Top conditions involved for these people * :

1. Parkinson's disease (14 people, 23.73%)
2. Prolactinoma (7 people, 11.86%)
3. Hyperprolactinaemia (7 people, 11.86%)
4. Acromegaly (5 people, 8.47%)
5. Pituitary tumour benign (4 people, 6.78%)

Login or sign up (it's free) to view more results.

Top co-used drugs for these people * :

1. Dostinex (7 people, 11.86%)
2. Symmetrel (5 people, 8.47%)
3. Comtan (5 people, 8.47%)
4. Carbidopa and levodopa (5 people, 8.47%)
5. Wypax (5 people, 8.47%)

Login or sign up (it's free) to view more results.

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: check whether nausea is from a drug or a condition

You can also:

• get notified of updates of this study
• post a comment or see what 1 people said
• let eHealthMe monitor your drugs
• get our mobile app: never miss a symptom, compare it with patients like me in real time, and discuss it with doctors later

On eHealthMe, Cabergoline (cabergoline) is often used for prolactinoma. Find out below the conditions Cabergoline is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.

What is Cabergoline used for and how effective is it:

• Cabergoline is used in:
  • Prolactinoma
  • Pituitary tumor
  • Hyperprolactinaemia
  • Pituitary tumour
  • Pituitary tumour benign

Other drugs that are used to treat the same conditions:

• Cabergoline alternatives:
  • Prolactinoma (3 drugs)
  • Pituitary tumor (3 drugs)
  • Hyperprolactinaemia (3 drugs)
  • Pituitary tumour (1 drug)
  • Pituitary tumour benign (3 drugs)

Could it be a symptom from a condition:

• Nausea in Prolactinoma (8 reports)
• Nausea in Pituitary Tumor
• Nausea in Hyperprolactinaemia (31 reports)
• Nausea in Pituitary Tumour (17 reports)
• Nausea in Pituitary Tumour Benign (12 reports)

Browse Cabergoline side effects from A to Z:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Browse Cabergoline drug interactions with drugs from A to Z:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Drugs in real world that are associated with:

• Nausea

Comments from related studies:

• From this study (13 months ago):

Does taking Cabergoline 0.25mg twice weekly alter the effectiveness of the depo provera shot?

Reply

Recent related drug checks on eHealthMe:

• Depo-provera (Pharmacia And Upjohn) - 150MG/ML, Cabergoline (Par Pharm) - 0.5MG drug interactions for Birth Control, Pituitary Tumor: Nausea
• Cabergoline side effects for Prolactinoma - Females: Nausea
• Cabergoline, Chantix drug interactions for Pituitary Tumour, Smoking Cessation Therapy: Nausea
• Levoxyl, Dostinex, Cabergoline drug interactions for Thyroid Disorder, Pituitary Tumour, Hyperprolactinaemia, Pituitary Tumour Benign: Nausea
• Cabergoline side effects for Prolactinoma: Nausea
• Somatuline Depot, Cabergoline, Nexium drug interactions for Acromegaly: Nausea
• Cabergoline, Lendormin, Wypax, Gaster D, Gasmotin, Maglax, Comtan, Carbidopa And Levodopa drug interactions for Parkinson's Disease: Nausea
• Comtan, Carbidopa And Levodopa, Cabergoline, Lendormin, Wypax, Famotidine, Gasmotin, Maglax drug interactions for Parkinson's Disease: Nausea
• Comtan, Carbidopa And Levodopa, Cabergoline, Lendormin, Wypax, Gaster, Gasmotin, Maglax drug interactions for Parkinson's Disease: Nausea
• Cabergoline side effects for Prolactinoma: Nausea

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent drug studies on eHealthMe: